Original filing (PDF)20251006135742NAL0006198416001

LIFEMD SOUTHERN PATIENT CARE, PC

Name: LIFEMD SOUTHERN PATIENT CARE, PC — LIFEMD SOUTHERN PATIENT CARE 401(K) PLAN, Form 5500 (2024)
Creator: LIFEMD SOUTHERN PATIENT CARE, PC

Form 5500-SF

FILING_RECEIVED

LIFEMD SOUTHERN PATIENT CARE 401(K) PLAN

401(k) retirement plan

Active participants

Accounts w/ balance

Plan assets (EOY)

$1.3M

Net assets (EOY)

$1.3M

Plan health score (directional)

/ 100

Grade A

Top-tier plan health

Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.

Compliance & disclosures

100

Concentration risk

Total plan cost

Vendor stack

100

Participation health

Decision-maker contacts

CFO / Head of HR / Benefits Manager — verified email + LinkedIn for LIFEMD SOUTHERN PATIENT CARE, PC.

Plan sponsor

Name

LIFEMD SOUTHERN PATIENT CARE, PC

EIN

86-3971722

Address

800 THIRD AVENUE · SUITE 2800 · NEW YORK, NY · 10022

Phone

(917) 902-3689

Industry

Retail Tradesee all

Plan administrator

Same as plan sponsor.

Plan characteristics

Plan number

001

Plan year

2024

Plan year begin

2024-01-01

Tax period

2024-12-31

Filed

2025-10-06

Pension benefit codes

2S · Automatic enrollment

2E · Profit-sharing

3D · Pre-approved plan (master / prototype / VS)

2G · Total participant-directed accounts

2J · 401(k) feature

2K · 401(m) arrangement

2F · ERISA section 404(c)

2T · Default investment account (QDIA)

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans

Similar-size Retail Trade plans

VALU DRUGS INC.

VALU DRUGS INC. CASH BALANCE PLAN

$1.3M · 4 participants

AJANTA PHARMACY CORP.

AJANTA PHARMACY CORP. 401(K) NEW COMPARABILITY PROFIT SHARING PLAN

$1.3M · 3 participants

PRESCRIPTION COMPOUNDING SPECI

PRESCRIPTION COMPOUNDING SPECI 401(K) PROFIT SHARING PLAN & TRUST

$1.3M · 11 participants

WELLNESS CENTER PHARMACY, INC. DBA DESIGNER DRUGS

THE WELLNESS PHARMACY 401(K) PROFIT SHARING PLAN

$1.3M · 27 participants

HARPERS PHARMACY INC